Brief Report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study-Reference-Cited by-同舟云学术

Brief Report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study

Published:2012-11-28 Issue:12 Volume:64 Page:4072-4077
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Saggar Rajeev,Khanna D.,Shapiro S.,Furst D. E.,Maranian P.,Clements P.,Abtin F.,Dua Shiv,Belperio J.,Saggar Rajan

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.34614/fullpdf

Reference19 articles.

1. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease;Mathai;Arthritis Rheum,2009

2. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension;Campo;Am J Respir Crit Care Med,2010

3. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era;Condliffe;Am J Respir Crit Care Med,2009

4. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities;Saggar;Arthritis Rheum,2010

5. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma;Kovacs;Am J Respir Crit Care Med,2009

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study;BMC Pulmonary Medicine;2024-02-17

3. Exercise Testing in Patients with Pulmonary Hypertension;Journal of Clinical Medicine;2024-01-30

4. Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention— prospective, single-center, randomized, parallel-group study;2023-08-23

5. Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?;Current Opinion in Pulmonary Medicine;2023-07-14